PRADAXA 150MG 30CAP

560.00 EGP

the active substance is dabigatran,which is administered in the form of 150 mg dabigatran etexilate given as mesilate .

PRADAXA 150MG 30CAP; dabigatran, cardiovascular agents .

ACTIVE-INGREDIENT OF PRADAXA 150MG 30CAP

the active substance is dabigatran , which is administered in the form of 150 mg dabigatran etexilate given as mesilate .

INDICATION OF PRADAXA 150MG 30CAP

pradaxa is a medicine which is used to reduce the risk of brain or body vessel obstruction by blood clot formation in adult patients with an abnormal heart beat ( arterial fibrillation ) and additional risk factors . Pradaxa is a blood thinner medicine that lowers the risk of blood clot formation . pradaxa is a medicine which is used to treat blood clots in the veins of your legs and lungs and to prevent blood clots from re-occuring in the vein of your legs and lungs .

DOSAGE OF PRADAXA 150MG 30CAP

Follow all directions given to you by your pharmacist or doctor carefully . They may differ from the information contained in this leaflet

Ask your pharmacist or doctor for help if you do not understand the instructions on the box .

The recommended dose is : –

always take this medicine exactly as your doctor has told you . Check with your doctor if you are not sure . The recommended dose is 300 mg taken as one 150 mg capsule twice a day . If you are 80 years or older , the recommended dose of pradaxa is 220 mg taken as one 110 mg capsule twice daily . if you are taking verapamil – containing medicines , you should be treated with a reduced pradaxa dose of 220 mg taken as one 110 mg capsule twice a day , because your bleeding risk may be increased , if you have a potentially higher risk for bleeding , your doctor may decide to prescribe dose of pradaxa 220 mg taken as one 110 mg capsule twice a day . pradaxa can be taken with or without food . the capsule should be swaalowed whole with a glass of water to ensure delivery to the stomach . do not break , chew , or empty the pellets from the capsule since this may increase the risk of bleeding . when taking pradaxa capsules out of the blister pack please observe the following instructions : talke the capsules by peeling off the backing foil of the blister card . do not push the capsules through the blister foil . do not peel off the blister foil until a capsule is required . change of anticoagulant treatment : changing from treatment with pradaxa to anticoagulant treatment given by injection : do not start treatment given by injectable anticoagulant medicines ( for example , heparin ) until 12 hours after the final dose of pradaxa . changing from anticoagulant treatment given by injection to treatment with pradaxa : start taking pradaxa 0-2 hours before the time you would havbe had the next injection . changing from pradaxa to blood thinners containing vitamin – k antagonists (e.g. phenprocoumon ) : your doctor needs to do blood – meaasurements and instruct you when to start vitamin – k antagonist treatment . changing from blood thinners containing vitamin – k antagonists ( e.g. phenprocoumon ) to pradaxa : stop taking the medicine containing a vitamin -k antagonist . your doctor needs to do blood – measurements and instruct you when to start pradaxa treatment .

OVER-DOSAGE OF PRADAXA 150MG 30CAP

if you take more pradaxa than recommended , you may have an increased risk of bleeding . Your doctor can perform a blood test to assess the risk of bleeding . Inform your doctor immediately , if you take more than the prescribed dose of pradaxa . If bleeding occurs , surgical treatment or treatmernt with blood transfusions may be required .

CONTRA-INDICATION OF PRADAXA 150MG 30CAP

do not take pradaxa : if you are allergic to dabigatran or any of the other ingerdients of this medicine . If you have severly reduced kidney function . If you are currently bleeding . If you have a disease in an organ of the body that increases the risk of serious bleeding . if you have an increased tendency to bleed . this nmay be inborn , of unknown cause or due to other medicines . if you have a severely reduced liver function or liver disease which could possibly cause death . if you are taking oral ketoconazole or itraconzole , medicines to treat fungal infections . if you are taking cyclosporine , a medicine to prevent organ rejection after transoplantation . if you are taking dronedarone , a medicine used to prevent repetition of your problem or irregular heart beat . if you are taking medicines to prevent blood clotting ( e.g. warfarin , rivaroxaban , apixaban or heparin ) , except when changing anticoagulant treatment or while having a venous or arterial line and you get heparin throught this line to keep it open . if you have received an artificial heart valve .

STORAGE OF PRADAXA 150MG 30CAP

store below 30 C , in the ioriginal package in order to protect from moisure .
PACK OF PRADAXA 150MG 30CAP
pradaxa 150 mg hard capsules are available in packs containing 10 ( 10’s blister X 1 ) , 30 ( 10’s blister X 3 ) , 60 ( 10’s blister X 6 ) a multipack containing 3 packs of 60 hard capsules (180 hard capsules ) or a multipack containing 2 packs of 50 hard capsules ( 100 hard capsules ) in aluminium perforated unit dose blisters . not all pack sizes may be marketed .
PRADAXA 150MG 30CAP MANUFACTURED BY
Boehringer Ingelheim Pharma GmbH & Co . KG Binger streasse 173 55216 Ingelheim am Rhein Germany .

https://www.pradaxa.com/

https://www.gardeniapharmacy.com/category/medicine-2/

Form

Gender

How to use

Reviews

There are no reviews yet.

Show reviews in all languages (1)

Be the first to review “PRADAXA 150MG 30CAP”

Your email address will not be published. Required fields are marked *

Shopping Cart
Don`t copy text!
Scroll to Top
Open chat